Ligand profile
1S6
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01389 — Beta-lactamase OXA-9
Identifiers
Database identifiers and provenance.
- Ligand ID
1S6- PDB
2iwd- UniProt (similar protein)
P0A0B0- Target protein
- KP13_01389
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 121.5
- −1 ≤ LogP ≤ 5 1.84
- MW ≤ 500 Da 403.5
- LogP ≤ 5 1.84
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 121.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c(no1)c2ccccc2)C(=O)N[C@H](C=O)[C@@H]3N[C@H](C(S3)(C)C)C(=O)OCc1c(c(no1)c2ccccc2)C(=O)N[C@H](C=O)[C@@H]3N[C@H](C(S3)(C)C)C(=O)O
InChI=1S/C19H21N3O5S/c1-10-13(14(22-27-10)11-7-5-4-6-8-11)16(24)20-12(9-23)17-21-15(18(25)26)19(2,3)28-17/h4-9,12,15,17,21H,1-3H3,(H,20,24)(H,25,26)/t12-,15+,17-/m1/s1InChI=1S/C19H21N3O5S/c1-10-13(14(22-27-10)11-7-5-4-6-8-11)16(24)20-12(9-23)17-21-15(18(25)26)19(2,3)28-17/h4-9,12,15,17,21H,1-3H3,(H,20,24)(H,25,26)/t12-,15+,17-/m1/s1
QXXMSXCGXIRLPM-ISTRZQFTSA-NQXXMSXCGXIRLPM-ISTRZQFTSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00905
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 1S6 →
- PDB RCSB structure 2iwd →
- UniProt UniProt P0A0B0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “1S6”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01389.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 48
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).